Sandoz' Hexal Wins Landmark German Case Over Desloratadine Switch
Executive Summary
Sandoz, through its Hexal subsidiary, has won an important case against the German Ministry of Health over a delayed prescription-to-OTC switch of desloratadine, which shows European Union Member States have got the authority to switch at a national level centrally authorized drugs.